localized transitional cell cancer of the renal pelvis and ureter
Showing 1 - 25 of >10,000
Blood and Tissue Samples From Locally Recurrent or Metastatic
Recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2021
Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,
Recruiting
- Bladder Carcinoma
- +7 more
- Atezolizumab
- +5 more
-
Toronto, Ontario, CanadaUniversity Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022
Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)
Not yet recruiting
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- (no location specified)
Nov 7, 2023
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial
Available
- Urothelial Cancer of Renal Pelvis
- +5 more
- Mitomycin for pyelocalyceal solution
- (no location specified)
Aug 5, 2022
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,
Active, not recruiting
- Hydronephrosis
- +18 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +13 more
- Pembrolizumab
- Propranolol Hydrochloride
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 8, 2022
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in
Active, not recruiting
- Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
- +17 more
- Gemcitabine Hydrochloride
-
Jacksonville, Florida
- +3 more
Jul 5, 2022
Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral
Recruiting
- Locally Advanced Renal Pelvis Urothelial Carcinoma
- +20 more
- Atezolizumab
- +2 more
-
Duarte, California
- +16 more
Aug 10, 2022
Transitional Cell Cancer of Renal Pelvis and Ureter Trial in New York, Myrtle Beach, Paris (padeliporfin VTP)
Recruiting
- Transitional Cell Cancer of Renal Pelvis and Ureter
- padeliporfin VTP
-
Albany, New York
- +6 more
Jan 3, 2023
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +18 more
- Enfortumab Vedotin
- Erdafitinib
-
Los Angeles, California
- +2 more
Jun 28, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)
Not yet recruiting
- Renal Pelvis and Ureter Urothelial Carcinoma
- Biopsy
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in
Recruiting
- Urothelial Cancer
- +3 more
- Sacituzumab Govitecan (SG)
- Enfortumab vedotin-ejfv (EV)
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 28, 2022
Renal Pelvis and Ureter Urothelial Carcinoma Trial in Houston (drug, other, procedure)
Active, not recruiting
- Renal Pelvis and Ureter Urothelial Carcinoma
- Infigratinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2022
Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)
Withdrawn
- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer
- tivozanib
- therapeutic conventional surgery
- (no location specified)
Aug 11, 2022
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Ureteral Tumors Trial in Roskilde (Lymphadenectomy in conjugation with nephroureterectomy, Nephroureterectomy without
Recruiting
- Ureteral Neoplasms
- Lymphadenectomy in conjugation with nephroureterectomy
- Nephroureterectomy without lymphadenectomy
-
Roskilde, DenmarkRoskilde Hospital
Sep 16, 2021
Urothelial Carcinoma Trial in United States (Enfortumab Vedotin, Radical surgery)
Not yet recruiting
- Urothelial Carcinoma
- Enfortumab Vedotin
- Radical surgery
-
Basking Ridge, New Jersey
- +6 more
May 11, 2023
Renal Cell Carcinoma Trial (Internet-Based Intervention - Complete iConquerFear program, Quality-of-Life Assessment,
Withdrawn
- Renal Cell Carcinoma
- Internet-Based Intervention - Complete iConquerFear program
- +2 more
- (no location specified)
Jun 7, 2022